Cargando…

Nitric Oxide Synthase Inhibition as a Neuroprotective Strategy Following Hypoxic–Ischemic Encephalopathy: Evidence From Animal Studies

BACKGROUND: Hypoxic–ischemic encephalopathy following perinatal asphyxia is a leading cause of neonatal death and disability worldwide. Treatment with therapeutic hypothermia reduced adverse outcomes from 60 to 45%. Additional strategies are urgently needed to further improve the outcome for these n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favié, Laurent M. A., Cox, Arlette R., van den Hoogen, Agnes, Nijboer, Cora H. A., Peeters-Scholte, Cacha M. P. C. D., van Bel, Frank, Egberts, Toine C. G., Rademaker, Carin M. A., Groenendaal, Floris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916957/ https://www.ncbi.nlm.nih.gov/pubmed/29725319 http://dx.doi.org/10.3389/fneur.2018.00258

Ejemplares similares

Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets
por: Alderliesten, Thomas, et al.
Publicado: (2014)

Correction: Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets
por: Alderliesten, Thomas, et al.
Publicado: (2015)

Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010)

Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five Metabolites
por: Favié, Laurent M. A., et al.
Publicado: (2020)

Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen
por: Favié, Laurent M.A., et al.
Publicado: (2020)

Pathophysiology of Cerebral Hyperperfusion in Term Neonates With Hypoxic-Ischemic Encephalopathy: A Systematic Review for Future Research
por: Kleuskens, Dianne G., et al.
Publicado: (2021)

Magnetic Resonance Imaging in (Near-)Term Infants with Hypoxic-Ischemic Encephalopathy
por: Parmentier, Corline E. J., et al.
Publicado: (2022)

Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia
por: Favié, Laurent M. A., et al.
Publicado: (2019)

Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
por: Zwart, Tom C., et al.
Publicado: (2018)

Pulmonary Effects of Neonatal Hydrocortisone Treatment in Ventilator-Dependent Preterm Infants
por: de Jong, Sandra E. A., et al.
Publicado: (2011)

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016)

Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
por: Dixon, Brandon J., et al.
Publicado: (2015)

New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy
por: Victor, Suresh, et al.
Publicado: (2021)

Automatic quantification of ischemic injury on diffusion-weighted MRI of neonatal hypoxic ischemic encephalopathy
por: Murphy, Keelin, et al.
Publicado: (2017)

Neuroprotective Effects of MicroRNA-210 on Hypoxic-Ischemic Encephalopathy
por: Qiu, Jie, et al.
Publicado: (2013)

Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
por: Sameshima, Hiroshi, et al.
Publicado: (2013)

The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)

Patterns of neonatal hypoxic–ischaemic brain injury
por: de Vries, Linda S., et al.
Publicado: (2010)

Mammillary body atrophy and other MRI correlates of school-age outcome following neonatal hypoxic-ischemic encephalopathy
por: Annink, Kim V., et al.
Publicado: (2021)

Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy
por: Weng, Bowen, et al.
Publicado: (2021)

Thiamine as a Possible Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Encephalopathy
por: Sechi, Gian Pietro, et al.
Publicado: (2021)

First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and -Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy  Subjects
por: van Hoogdalem, Ewoud-Jan, et al.
Publicado: (2020)

2-iminobiotin, a selective inhibitor of nitric oxide synthase, improves memory and learning in a rat model after four vessel occlusion, mimicking cardiac arrest
por: Peeters-Scholte, Cacha, et al.
Publicado: (2023)

Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review
por: Stegeman, Raymond, et al.
Publicado: (2018)

A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy – are we there yet?
por: Schulzke, Sven M, et al.
Publicado: (2007)

The development and validation of a cerebral ultrasound scoring system for infants with hypoxic-ischaemic encephalopathy
por: Annink, Kim V., et al.
Publicado: (2020)

Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
por: Rocha-Ferreira, Eridan, et al.
Publicado: (2018)

Necroptosis Blockade Potentiates the Neuroprotective Effect of Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy
por: Chevin, Mathilde, et al.
Publicado: (2022)

Annexin A1 as Neuroprotective Determinant for Blood-Brain Barrier Integrity in Neonatal Hypoxic-Ischemic Encephalopathy
por: Gussenhoven, Ruth, et al.
Publicado: (2019)

Perinatal Azithromycin Provides Limited Neuroprotection in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
por: Mike, Jana Krystofova, et al.
Publicado: (2023)

Novel Neuroprotective Agents to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Inter-Alpha Inhibitor Proteins
por: Koehn, Liam M., et al.
Publicado: (2020)

Oral Medicines for Children in the European Paediatric Investigation Plans
por: van Riet – Nales, Diana A., et al.
Publicado: (2014)

Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy
por: Park, Won Soon, et al.
Publicado: (2015)

Progesterone as a Neuroprotective Agent in Neonatal Hypoxic-Ischaemic Encephalopathy: A Systematic Review
por: Lee, Ming-Te, et al.
Publicado: (2022)

Prevention, Reduction and Repair of Brain Injury of the Preterm Infant
por: van Bel, Frank, et al.
Publicado: (2019)

Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review
por: Donners, Anouk A. M. T., et al.
Publicado: (2021)

Time Dependent Changes in the Ovine Neurovascular Unit; A Potential Neuroprotective Role of Annexin A1 in Neonatal Hypoxic-Ischemic Encephalopathy
por: Park, Hyun Young, et al.
Publicado: (2023)

PML regulates neuroprotective innate immunity and neuroblast commitment in a hypoxic–ischemic encephalopathy model
por: Palibrk, Vuk, et al.
Publicado: (2016)

The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status
por: Dumbuya, John Sieh, et al.
Publicado: (2021)

Comparison between coagulation factor VIII quantified with one‐stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle
por: Donners, Anouk A. M. T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv8v2du1ifqb7apkobn1g5pe03